Overall Survival Analysis From a Randomized Phase II Study of Axitinib With or Without Dose Titration in First-Line Metastatic Renal Cell Carcinoma

Autor: Rini, Brian I., Tomita, Yoshihiko, Melichar, Bohuslav, Ueda, Takeshi, Grünwald, Viktor, Fishman, Mayer N., Uemura, Hirotsugu, Oya, Mototsugu, Bair, Angel H., Andrews, Glen I., Rosbrook, Brad, Jonasch, Eric
Zdroj: In Clinical Genitourinary Cancer December 2016 14(6):499-503
Databáze: ScienceDirect
Externí odkaz: